A study has developed a reliable way to measure whether seriously ill hospitalized patients receive medical care that aligns with their personal goals. The research, involving 109 seriously ill ...
"These findings suggest that consciously generated positive expectations can engage reward circuitry to influence immune ...
Researchers say the results are encouraging but also shared cautions. More than half of children in early stages of an ongoing study were able to eat a food they were allergic to one year after ...
Stallergenes Greer, a global leader in allergy therapeutics, announced today that its Phase IIIb clinical study (YOBI, YOung patients and BIrch allergy), designed to confirm the safety and efficacy of ...
Halifax, Nova Scotia--(Newsfile Corp. - May 27, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to announce positive results from a required preclinical safety ...
LEWES, Del., Oct. 1, 2025 /PRNewswire/ -- Neteera Technologies Ltd. today announced results from a clinical study demonstrating that its contactless monitoring system achieved 77% sensitivity in ...
A team of international researchers developed a deep-learning system to screen patients for diabetic retinopathy and related eye diseases, according to a study published in JAMA Dec. 12. The ...
How small is "small?" Spider silk nanofibrils are just a few molecular layers thick, equivalent to approximately one ten-thousandth the diameter of a human hair. They're invisible to the naked eye and ...
DehydraTECH-semaglutide reduced overall side effects by 48% as compared to Rybelsus ® DehydraTECH-semaglutide reduced gastrointestinal side effects by 55% as compared to Rybelsus ® Recent financings ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc., (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced ...
Smartphone photographs provide a convenient avenue for direct parent-to-clinician teledermatology care, according to recent research published in JAMA Dermatology. Researchers from the Children’s ...
n = number of patients included in each study group for HbA1c and body weight efficacy assessments Abbreviations: EOS: End of Study (week 16); Wk: week; BID: twice daily; CBD: cannabidiol; QD: once ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback